In July 2026, the ex‑works price of glycine rebounded on the back of cost recovery and supply tightening and is expected to remain firm with an upside bias in the near term. Yellow phosphorus retreated from elevated levels, whilst the domestic glyphosate market stayed subdued under the same supply–demand pressures.
On the project front, the EI report for Jingzhou Newtrend's 60,000 t/a industrial‑grade glycine/40,000 t/a food‑grade glycine/50,000 t/a ammonium chloride product project was publicised on 30 June. On 2 July, the EI report for Goldwind Green Energy's green hydrogen-to-green methanol project (Phase III) was approved. On 7 July, the EI report for Sichuan Xinongwang's agrochemical formulation production project was accepted.
Regarding corporate updates, on 2 July, the EI report for Grand Huachen's 70,000 t/a glycine expansion project was accepted; Bayer requested the initiation of AD/CVD investigations on glyphosate imported from China; Hebang Biotech, Wynca Group, and Nanjing Red Sun disclosed their semi-annual earnings forecasts.
On the regulatory side, Shandong unveils plan to upgrade ageing petrochemical equipment; China issued the 15th Five‑Year Plan Carbon Peaking Action Plan, steering the chemical industry from capacity expansion towards a quality‑focused, tightly controlled growth model.
In export trade, Fuhua Tongda ranked first among Chinese glyphosate exporters in April 2026, with the US as the largest destination market.

